Merck: Keytruda's Sales Projections Outweigh Competitive And Patent Risks
Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...
Merck & Co., Inc. (MRK): Among the Best Low Volatility Stocks to Invest In Now
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
The global biopharmaceutical market saw a 2% increase in market capitalization in Q3 2024, led by growth from Bristol-Myers ...
The Globe and Mail5d
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
The S&P 500 index is up 20% year to date with several high-profile ... Pharmaceutical giant Merck(NYSE: MRK) is recognized ...
FiercePharma6d
Daiichi Sankyo links up with Korea's Alteogen on subcutaneous Enhertu in $300M licensing deal
A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...
Le Lézard9h
Melmark Welcomes First Elected Female Board Chair in 60 Years
Maureen is a Medical Director/Medical Consult and Review Physician in Infectious Disease and Vaccines for Merck. She received her medical degree ... She has been in practice for more than 20 years ...
pharmaphorum4d
How Merck is stepping up for patients
Over more than 20 years in the pharma industry ... and to direct R&D efforts where they can best help patients. To achieve this objective, in 2017, Merck launched a first-of-its-kind initiative ...